 |
|
Risk Factors for Fluoroquinolone Resistance in Nosocomial Escherichia coli and Klebsiella pneumoniae Infections
Ebbing Lautenbach, MD,MPH;
Neil O. Fishman, MD;
Warren B. Bilker, PhD;
Analia Castiglioni, MD;
Joshua P. Metlay, MD,PhD;
Paul H. Edelstein, MD;
Brian L. Strom, MD,MPH
Arch Intern Med. 2002;162:2469-2477.
Background The incidence of fluoroquinolone (FQ) resistance has increased markedly in recent years. Even in the common nosocomial pathogens Escherichia coli and Klebsiella pneumoniae, in which the emergence of FQ resistance was believed to be unlikely, increasing resistance to these agents has been noted. Risk factors for FQ resistance in these pathogens remain unknown. Although FQs are important components of the present antimicrobial arsenal, their continued usefulness is threatened by rising FQ resistance.
Objective To identify risk factors for nosocomial FQ resistance.
Methods A case-control study of hospitalized patients with infections due to FQ-resistant and FQ-susceptible E coli and K pneumoniae occurring between January 1, 1998, and June 30, 1999.
Results We included 123 patients with nosocomial FQ-resistant infections and 70 randomly selected patients with nosocomial FQ-susceptible infections. Independent risk factors (adjusted odds ratio [95% confidence interval]) for FQ resistance were (1) recent FQ use (5.25 [1.81-15.26]); (2) residence in a long-term care facility (3.65 [1.64-8.15]); (3) recent aminoglycoside use (8.86 [1.71-45.99]); and (4) older age (1.03 [1.01-1.06]).
Conclusions Recent FQ use, residence in a long-term care facility, recent aminoglycoside use, and older age were all noted to be independent risk factors for FQ resistance among patients with nosocomial E coli and K pneumoniae infections. Efforts should be directed at recognition and modification of these risk factors to curb the rise in FQ resistance and preserve the utility of these agents in the treatment of common nosocomial gram-negative infections.
From the Divisions of Infectious Diseases (Drs Lautenbach and Fishman) and General Internal Medicine (Drs Castiglioni, Metlay, and Strom) of the Department of Medicine, the Department of Biostatistics and Epidemiology (Drs Lautenbach, Bilker, Metlay, and Strom), the Department of Pathology and Laboratory Medicine (Dr Edelstein), the Center for Clinical Epidemiology and Biostatistics (Drs Lautenbach, Bilker, Metlay, and Strom), and the University of Pennsylvania Centers for Research and Education on Therapeutics (Drs Lautenbach, Metlay, and Strom), University of Pennsylvania School of Medicine, Philadelphia.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Impact of Empiric Antibiotic Therapy on Outcomes in Patients with Pseudomonas aeruginosa Bacteremia
Osih et al.
Antimicrob. Agents Chemother. 2007;51:839-844.
ABSTRACT
| FULL TEXT
Impact of Inadequate Initial Antimicrobial Therapy on Mortality in Infections Due to Extended-Spectrum {beta}-Lactamase-Producing Enterobacteriaceae: Variability by Site of Infection
Hyle et al.
Arch Intern Med 2005;165:1375-1380.
ABSTRACT
| FULL TEXT
Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes
Hsu et al.
J Antimicrob Chemother 2005;55:535-541.
ABSTRACT
| FULL TEXT
Fluoroquinolone consumption and resistance in haematology-oncology patients: ecological analysis in two university hospitals 1999-2002
Kern et al.
J Antimicrob Chemother 2005;55:57-60.
ABSTRACT
| FULL TEXT
Colonization with Extraintestinal Pathogenic Escherichia coli among Nursing Home Residents and Its Relationship to Fluoroquinolone Resistance
Maslow et al.
Antimicrob. Agents Chemother. 2004;48:3618-3620.
ABSTRACT
| FULL TEXT
Risk Factors for Community-Acquired Ciprofloxacin-Resistant Escherichia coli Urinary Tract Infection
Killgore et al.
The Annals of Pharmacotherapy 2004;38:1148-1152.
ABSTRACT
| FULL TEXT
The Magnitude of the Association between Fluoroquinolone Use and Quinolone-Resistant Escherichia coli and Klebsiella pneumoniae May Be Lower than Previously Reported
Bolon et al.
Antimicrob. Agents Chemother. 2004;48:1934-1940.
ABSTRACT
| FULL TEXT
|
